Structural Basis of Dilated Cardiomyopathy

扩张型心肌病的结构基础

基本信息

  • 批准号:
    10183307
  • 负责人:
  • 金额:
    $ 38.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT The overall goal of this research proposal is to determine the molecular and structural determinants for dilated cardiomyopathy (DCM) linked to phospholamban (PLN), a membrane protein involved in Ca2+ transport in the sarcoplasmic reticulum (SR). PLN binds and reversibly inhibits the SR Ca-ATPase (SERCA), regulating heart diastole in response to Ca2+ and -adrenergic signaling pathways. -adrenergic control of PLN via reversible phosphorylation at Ser16 relieves PLN’s inhibitory effects to restore SERCA’s basal activity, while shifts in cytosolic Ca2+ levels modulate PLN interactions with SERCA. PLN’s position at the crossroads of Ca2+ signaling and -adrenergic stimulation makes it a key regulator for cardiac output. Here, we propose to analyze the effects of new lethal mutants of PLN (PLNR9H, PLNR9L, and PLNR25C; AIM1) as well as its post-translational modifications (O-linked N-Glycosylation at Ser16 and S-Acylation at Cys36; AIM2) found in patients diagnosed with DCM and understand how they affect Ca2+ cycling. We will employ an integrated approach including biochemical, molecular biology, and spectroscopic methods (FRET, solution NMR, magic angle spinning, and oriented solid-state NMR) in concert with both in cell and in vivo experiments carried out independently by our collaborators. These experiments will determine the cardiotoxic mechanisms of these new mutants and PTMs to obtain a new, unifying regulatory model for cardiac contractility, bridging the Ca2+ and -adrenergic signaling pathways. Finally, in AIM3, we will investigate how to reverse PLN inhibito- ry effects as a mean to augment cardiac contractility under pathological conditions. The scientific premise of the latter AIM is based on our recent discovery that single-stranded oligonucleotides modulate PLN’s regula- tion of SERCA. Together, these studies will pave the way for understanding how mutations and PTMs disrupt Ca2+ and/or - adrenergic signaling, and how cardiac function may be rescued by restoring Ca2+ homeostatic balance.
摘要

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T2* weighted Deconvolution of NMR Spectra: Application to 2D Homonuclear MAS Solid-State NMR of Membrane Proteins.
NMR 谱图的 T2* 加权解卷积:在膜蛋白的 2D 同核 MAS 固态 NMR 中的应用。
  • DOI:
    10.1038/s41598-019-44461-3
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    VS,Manu;Gopinath,Tata;Wang,Songlin;Veglia,Gianluigi
  • 通讯作者:
    Veglia,Gianluigi
Cytoplasmic nucleic acid-based XNAs directly enhance live cardiac cell function by a Ca2+ cycling-independent mechanism via the sarcomere.
基于细胞质核酸的 XNA 通过肌节的 Ca2 循环独立机制直接增强活心脏细胞功能。
  • DOI:
    10.1016/j.yjmcc.2019.02.016
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Thompson,BrianR;Soller,KaileyJ;Vetter,Anthony;Yang,Jing;Veglia,Gianluigi;Bowser,MichaelT;Metzger,JosephM
  • 通讯作者:
    Metzger,JosephM
Proton-detected polarization optimized experiments (POE) using ultrafast magic angle spinning solid-state NMR: Multi-acquisition of membrane protein spectra.
使用超快魔角旋转固态 NMR 的质子检测偏振优化实验 (POE):膜蛋白光谱的多次采集。
CHESPA/CHESCA-SPARKY: automated NMR data analysis plugins for SPARKY to map protein allostery
CHESPA/CHESCA-SPARKY:SPARKY 的自动化 NMR 数据分析插件,用于绘制蛋白质变构图
  • DOI:
    10.1093/bioinformatics/btaa781
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Shao, Hongzhao;Boulton, Stephen;Olivieri, Cristina;Mohamed, Hebatallah;Akimoto, Madoka;Subrahmanian, Manu Veliparambil;Veglia, Gianluigi;Markley, John L;Melacini, Giuseppe;Lee, Woonghee
  • 通讯作者:
    Lee, Woonghee
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gianluigi Veglia其他文献

Gianluigi Veglia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gianluigi Veglia', 18)}}的其他基金

Console Upgrade for a 600 MHz NMR Spectrometer
600 MHz NMR 波谱仪的控制台升级
  • 批准号:
    9075022
  • 财政年份:
    2016
  • 资助金额:
    $ 38.24万
  • 项目类别:
Mapping Allosteric Cooperativity in Protein Kinases
绘制蛋白激酶的变构协同性
  • 批准号:
    8230294
  • 财政年份:
    2012
  • 资助金额:
    $ 38.24万
  • 项目类别:
Mapping Allosteric Cooperativity in Protein Kinases
绘制蛋白激酶的变构协同性
  • 批准号:
    8819551
  • 财政年份:
    2012
  • 资助金额:
    $ 38.24万
  • 项目类别:
Mapping Allosteric Cooperativity in Protein Kinases
绘制蛋白激酶的变构协同性
  • 批准号:
    8625314
  • 财政年份:
    2012
  • 资助金额:
    $ 38.24万
  • 项目类别:
Mapping Allosteric Cooperativity in Protein Kinases
绘制蛋白激酶的变构协同性
  • 批准号:
    9749974
  • 财政年份:
    2012
  • 资助金额:
    $ 38.24万
  • 项目类别:
Mapping Allosteric Cooperativity in Protein Kinases
绘制蛋白激酶的变构协同性
  • 批准号:
    8449105
  • 财政年份:
    2012
  • 资助金额:
    $ 38.24万
  • 项目类别:
STRUCTURE AND DYNAMICS OF PKA
PKA的结构和动力学
  • 批准号:
    8361154
  • 财政年份:
    2011
  • 资助金额:
    $ 38.24万
  • 项目类别:
STRUCTURE AND DYNAMICS OF PKA
PKA的结构和动力学
  • 批准号:
    8168940
  • 财政年份:
    2010
  • 资助金额:
    $ 38.24万
  • 项目类别:
STRUCTURE AND DYNAMICS OF PKA
PKA的结构和动力学
  • 批准号:
    7954611
  • 财政年份:
    2009
  • 资助金额:
    $ 38.24万
  • 项目类别:
STRUCTURE AND DYNAMICS OF PKA
PKA的结构和动力学
  • 批准号:
    7721636
  • 财政年份:
    2008
  • 资助金额:
    $ 38.24万
  • 项目类别:

相似海外基金

Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
  • 批准号:
    BB/Y003756/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.24万
  • 项目类别:
    Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
  • 批准号:
    MR/Y503435/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.24万
  • 项目类别:
    Research Grant
S-acylation-dependent regulation of cytokine receptor signaling and cardiac maladaptation
细胞因子受体信号传导和心脏适应不良的 S-酰化依赖性调节
  • 批准号:
    10561406
  • 财政年份:
    2023
  • 资助金额:
    $ 38.24万
  • 项目类别:
Comprehensive analysis of acidic patch binder using histone acylation catalysts
使用组蛋白酰化催化剂综合分析酸性贴片粘合剂
  • 批准号:
    22KJ1113
  • 财政年份:
    2023
  • 资助金额:
    $ 38.24万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
S-Acylation of transmembrane proteins in the early secretory pathway
早期分泌途径中跨膜蛋白的 S-酰化
  • 批准号:
    BB/X001504/1
  • 财政年份:
    2023
  • 资助金额:
    $ 38.24万
  • 项目类别:
    Research Grant
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
  • 批准号:
    10584620
  • 财政年份:
    2022
  • 资助金额:
    $ 38.24万
  • 项目类别:
The Molecular Mechanisms of Glycolytic Enzyme S-acylation in Neurons
神经元糖酵解酶S-酰化的分子机制
  • 批准号:
    576016-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 38.24万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
用于精准基因组编辑的抗 CRISPR 介导的酰化和生物可逆酯化
  • 批准号:
    10657417
  • 财政年份:
    2022
  • 资助金额:
    $ 38.24万
  • 项目类别:
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
YEATS2 组蛋白酰化酶抑制剂的高通量筛选
  • 批准号:
    10389517
  • 财政年份:
    2022
  • 资助金额:
    $ 38.24万
  • 项目类别:
Roles of KAT8 complexes in governing histone acylation and mouse cerebral development
KAT8复合物在控制组蛋白酰化和小鼠大脑发育中的作用
  • 批准号:
    RGPIN-2019-07122
  • 财政年份:
    2022
  • 资助金额:
    $ 38.24万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了